These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1623227

  • 21. [Therapeutic results: tacrine].
    Ventura M, Sternon J.
    Rev Med Brux; 1997 Dec; 18(6):394-7. PubMed ID: 9481161
    [Abstract] [Full Text] [Related]

  • 22. [Tacrine in Alzheimer's disease].
    López de Munain A.
    Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
    [No Abstract] [Full Text] [Related]

  • 23. Cholinergic therapy in dementia.
    Whitehouse PJ.
    Acta Neurol Scand Suppl; 1993 Jul; 149():42-5. PubMed ID: 8128838
    [Abstract] [Full Text] [Related]

  • 24. Benzodiazepine utilization patterns in Alzheimer's disease patients.
    Lagnaoui R, Moore N, Moride Y, Miremont-Salamé G, Bégaud B.
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):511-5. PubMed ID: 14513664
    [Abstract] [Full Text] [Related]

  • 25. Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma.
    Peskind ER, Wingerson D, Pascualy M, Thal L, Veith RC, Dorsa DM, Bodenheimer S, Raskind MA.
    Biol Psychiatry; 1995 Oct 15; 38(8):532-8. PubMed ID: 8562665
    [Abstract] [Full Text] [Related]

  • 26. Donepezil (Aricept) therapy for Alzheimer's disease.
    Geldmacher DS.
    Compr Ther; 1997 Jul 15; 23(7):492-3. PubMed ID: 9262925
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Alzheimer's disease management.
    Cummings JL.
    J Clin Psychiatry; 1998 Jul 15; 59 Suppl 13():4-5. PubMed ID: 9771824
    [No Abstract] [Full Text] [Related]

  • 30. Alzheimer's disease: new pharmacological perspectives.
    Palacios JM.
    Methods Find Exp Clin Pharmacol; 1996 Jul 15; 18 Suppl B():67-8. PubMed ID: 8899698
    [No Abstract] [Full Text] [Related]

  • 31. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
    Antuono PG.
    Arch Intern Med; 1995 Sep 11; 155(16):1766-72. PubMed ID: 7654110
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia.
    Trzepacz PT, Ho V, Mallavarapu H.
    Psychosomatics; 1996 Sep 11; 37(3):299-301. PubMed ID: 8849507
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.